Revenue Breakdown
Composition ()
No data
Revenue Streams
Resmed Inc (RMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Devices, accounting for 50.9% of total sales, equivalent to $680.31M. Another important revenue stream is Masks and other. Understanding this composition is critical for investors evaluating how RMD navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Resmed Inc maintains a gross margin of 60.56%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 34.62%, while the net margin is 26.10%. These profitability ratios, combined with a Return on Equity (ROE) of 25.41%, provide a clear picture of how effectively RMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RMD competes directly with industry leaders such as MDLN and GEHC. With a market capitalization of $37.31B, it holds a significant position in the sector. When comparing efficiency, RMD's gross margin of 60.56% stands against MDLN's 23.87% and GEHC's 38.67%. Such benchmarking helps identify whether Resmed Inc is trading at a premium or discount relative to its financial performance.
